Gouin, Kenneth H. III
Ing, Nathan
Plummer, Jasmine T. http://orcid.org/0000-0001-7263-350X
Rosser, Charles J. http://orcid.org/0000-0002-6052-4223
Ben Cheikh, Bassem
Oh, Catherine
Chen, Stephanie S.
Chan, Keith Syson
Furuya, Hideki http://orcid.org/0000-0002-9536-8662
Tourtellotte, Warren G.
Knott, Simon R. V.
Theodorescu, Dan http://orcid.org/0000-0002-8708-8206
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA075115)
Article History
Received: 17 November 2020
Accepted: 22 July 2021
First Online: 12 August 2021
Competing interests
: K.H.G., N.I., C.J.R., S.R.V.K., and D.T. have filed a provisional patent (Application no. 63/197,129 “USE OF CANCER CELL EXPRESSION OF CADHERIN 12 AND CADHERIN 18 TO TREAT MUSCLE INVASIVE AND METASTATIC BLADDER CANCERS”) based on the biomarker features of the CDH12 population defined in this work. All other authors declare no competing interests.